The CHD1-PTEN synthetic lethal relationship may even be exploited further using immune checkpoint inhibition given CHD1’s role in maintaining an elevated level of myeloid-derived suppressor cells in Pten-deficient prostate cancers [222]. Here, PTEN is linked to prostate carcinoma.